CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CMEDEnrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 Productive initial meeting with the FDA on Auxora in acute pancreatitis (AP); conversations continue, with alignment on a pivotal trial anticipated...
August 12, 2025Earnings
Read more →